Exosomes in development, metastasis and drug resistance of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exosomes in development, metastasis and drug resistance of breast cancer

Published:2015-07-20 Issue:8 Volume:106 Page:959-964
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yu Dan‐dan¹²,Wu Ying¹²,Shen Hong‐yu²,Lv Meng‐meng¹,Chen Wei‐xian¹²,Zhang Xiao‐hui³,Zhong Shan‐liang³,Tang Jin‐hai²,Zhao Jian‐hua³

Affiliation:

1. The First Clinical School of Nanjing Medical University NanjingChina

2. Department of General Surgery Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province NanjingChina

3. Center of Clinical Laboratory Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province Nanjing China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12715

Reference69 articles.

1. Breast cancer statistics, 2013

2. Breast cancer statistics and markers;Donepudi MS;J Cancer Res Ther,2014

3. miRNAs in breast cancer tumorigenesis (Review)

4. Alpha-Actinin 4 and Tumorigenesis of Breast Cancer

5. Roles of Aurora‐A in tumorigenesis and prognosis of breast cancer;Xia LP;Ai Zheng,2009

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration;Drug Resistance Updates;2024-09

2. Unraveling the Connection: Extracellular Vesicles and Non-Small Cell Lung Cancer;International Journal of Nanomedicine;2024-08

3. Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis;Hematology;2024-07-26

4. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities;Mutation Research - Reviews in Mutation Research;2024-07

5. Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms;Cancer Letters;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3